The purpose of this clinical pilot study is to evaluate the effects of the MR-010 on tolerability, biomechanics and walking speed in the acute stroke care setting in addition to its impact on length of stay.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
4
MR-010 includes a patient application and sensors with commercially available headphones and smartphones. Sensors are placed on the subject's shoes and measure gait metrics. The algorithm uses data from the sensors to inform changes made to the audio cues. These cues, which are embedded in time-shifted music, are delivered back to the users who aim to walk to the beat.
UMass Chan Medical School
Worcester, Massachusetts, United States
Change in Gait Speed (m/s)
Change in gait speed (m/s) from baseline to study completion as measured by a 6 meter walking test.
Time frame: 90 days
Adherence to MR-010 Therapy Schedule
Adherence to the MR-010 therapy schedule is measured by the number of participants who completed scheduled sessions (3 times per week for 12 weeks)
Time frame: 90 days
Length of Stay
Median length of stay in acute stroke hospital
Time frame: Duration of hospital stay, up to 14 days
Readmission to Hospital
Percent of readmission to hospital following discharge
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.